Adverse drug reactions as cause of visit to Emergency Department: Incidence, features and outcomes;Le reazioni awerse ai farmaci come causa di ricorso al Pronto Soccorso: Incidenza, caratteristiche e risultati

Recenti Progressi in Medicina

Volumn 97, Issue 7-8, 2006, Pages 381-388

  Zanocchi, Mauro ^a,b   Tibaldi, Vittoria ^a   Amati, Dario ^a   Francisetti, Federica ^a   Martinelli, Elisa ^a   Gonella, Mafalda ^a   Cerrato, Flavio ^a   Ponte, Elisabetta ^a   Luppino, Angela ^a   Bardelli, Benedetta ^a   Canadè, Antonella ^a   Gariglio, Federico ^a   Moiraghi, Corrado ^b   Molaschi, Mario ^a  

^a Dipartimento Discipline Medico Chirurgiche   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Adverse drug reactions; Elderly; Emergency Department; Hospitalization

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIPYRETIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; ANALGESIC AGENT; ANTIINFECTIVE AGENT; DRUG;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; CLINICAL ARTICLE; CONFUSION; DEMENTIA; DYSPNEA; EMERGENCY WARD; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATOMA; HOSPITAL ADMISSION; HUMAN; HYPOGLYCEMIA; INCIDENCE; MALE; MORTALITY; MULTIVARIATE ANALYSIS; RASH; SYNCOPE; VOMITING; WHEEZING; CHEMICALLY INDUCED DISORDER; DRUG ERUPTION; DRUG SURVEILLANCE PROGRAM; EMERGENCY HEALTH SERVICE; ITALY; MIDDLE AGED; STATISTICS; TREATMENT OUTCOME;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ANALGESICS, NON-NARCOTIC; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; CONFUSION; DRUG ERUPTIONS; EMERGENCY SERVICE, HOSPITAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; ITALY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHARMACEUTICAL PREPARATIONS; TREATMENT OUTCOME;

EID: 33746391471     PISSN: 00341193     EISSN: 00341193     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Jick H. Adverse drug reaction: the magnitude of the problem. J Allergy Clin Immunol 1984; 74: 555-7.
2. Vervloet D, Durham S. ABC of allergies. Adverse reactions to drugs. BMJ 1998; 316: 1511-14.
3. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ 2004; 329: 15-9.
4. Patel P, Zed PJ. Drug-related visits to the Emergengy Department: how big is the problem? Pharmacoterapy 2002; 22: 915-23.
5. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patiens: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-5.
6. Einarson TR. Drug-related hospital admissions. Ann Pharmacoter 1993; 27: 832-40.
7. Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24: 46-54.
8. Wiffen P, Gill M, Edwards J, Moore A. Adverse drug reactions in hospital patients. Bandolier Extra, June 2002.
9. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255-9.
10. Bates DW, Spell N, Cullen DJ, Burdick E, Petersen LA, Small SD, Sweitzer BJ, Leape LL. The cost of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997; 277: 307-11.
11. Leone R. Farmacovigilanza: la situazione italiana. www.farmacovigilanza. org
12. Hutchinson TA, Leventhal JM, Kramer MS, Karch FE, Lipman AG, Feinstein AR. An algorithm for the operational assessment of adverse drug reactions. II. Demonstration of reproducibility and validity. JAMA 1979; 242: 633-8.
13. Riedl MA, Casillas AM. Adverse drug reactions: types and treatment options. Am Fam Physician 2003; 68: 1781-90.
14. Descotes J, Choquet-Kastylevsky G. Gell and Coombs's classification: is it stilll valid? Toxicology 2001; 158: 43-9.
15. Bowman L, Carlstedt BC, Hancock EF, Black CD. Adverse drug reaction (ADR) occurrence and evaluation in elderly inpatiens. Pharmacoepidemiol Drug Saf 1996; 5: 9-18.
16. Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist 1970; 10: 20-30.
17. Pfeiffer E. A Short Portable Mental Status Questionnaire for the assessment of organic brain deficit in elderly patients. JAGS 1975; 10: 433-441.
18. US Department of Health and Human Services. The international classification of disease, 9th revision, clinical modification: ICD-9-CM 3rd ed. Washington: US Public Health Services Publication 1989.
19. Zanocchi M, Ponzetto M, Spada S, Maero B, Risso R, Aimar T, Fabris F, Friziero M. La politerapia nella pratica ambulatoriale del paziente anziano. Recenti Prog Med 1999; 90: 455-61.
20. World Health Organization. Safety monitoring of medical product. Guidelines for setting up and running a pharmacovigilance centre. Geneva 1996; 19.
21. Zhang Y. The gut as a barrier to drug absorption: combined role of cytochrome P450 3° and P-glycoprotein. Clin Pharmacokinet 2001; 40: 159-68.
22. Ross SD. Drug-Related Adverse Events. Arch intern Med. 2001; 161: 1041-46.
23. Miremont G, Haramburu F, Bègaud B, Pèrè JC, Dangoumau J. Adverse drug reactions: physiscians' opinions versus a causality assessment method. Eur J Clin Pharmacol 1994; 46: 285-89.
24. Tafreshi MJ, Melby MJ, Kaback KR, Nord TC. Medication-related visits to the emergency department: a prospective study. Ann Pharmacother 1999; 33: 1252-7.
25. Prince BS, Goetz CM, Rihn TL, Olsky M. Drug-related Emergency Department visits and hospital admissions. Am J Hosp Pharm 1992; 49: 1696-700.
26. Trifiro G, Calogero G, Ippolito FM, Cosentino M, Giuliani R, Conforti A, Venegoni M, Mazzaglia G, Caputi AP. Adverse drug events in Emergency Department population: prospective Italian study. Pharmacoepidemiol Drug Saf 2005; 14: 333-40.
27. Onder G, Pedone C, Landi F, Cesari M, Della Vedova C, Bernabei R, Gambassi G. Adverse drug reactions as cause of hospital admission: results from the Italian Group of Pharmacoepidemiology in the elderly (GIFA). J Am Geriatr Soc 2002; 12: 1962-8.
28. Roughead EE, Gibert AL, Primrose JG, Sansom LN. Drug-related hospital admission: a review of Australian studies published 1988-1996. Med J Aust 1998; 168: 405-8.
29. Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Begaud B. Adverse drug reactions in a Department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol 2000; 56: 181-6.
30. Manchon ND, Bercoff E, Lemarchand P, Chassagne P, Senant J, Burreille J. Incidence and severity of drug interactions in the elderly: a prospective study of 639 patients. Rev Med Interne 1989; 10: 521-5.
31. Ray WA, Griffin MR, Shorr RI. Adverse drug reactions and the elderly. Health Aff 1990; 9: 114-22.
32. Carbonin P, Pahor M, Bernabei R, Sgadari A. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc 1991; 39: 1093-9.
33. Moore N, Lecointre D, Noblet C, Mabille M. Frequency and cost of serious adverse drug reactions in a Department of general medicine. Br J Clin Pharmacol 1998; 45: 301-8.
34. Goettler M, Schneeweiss S, Hasford J. Adverse drug rections monitoring - cost and benefits considerations. Part II: Cost and preventability of adverse drug reactions leading to hospital admission. Pharmacoepidemiol Drug Saf 1997; 6: S79-9.
35. Goodman Gilman A. Farmacocinetica. In: Le basi farmacologiche della terapia. (Hardman J, Limbird L, Goodman Gilman A, a cura di). Traduzione italiana della decima edizione. Milano: McGraw-Hill 2003.
36. Hamilton RA, Briceland LL, Andritz MH. Frequency of hospitalization after exposure to known drug-drug interactions in a Medicaid population. Pharmacoterapy. 1998; 18: 1112-20.
37. Routledge P. 150 years of pharmacovigilance. Lancet 1998; 351: 1200-1.